Testing for PIK3CA and AKT1 mutations in tumors is important for several reasons, especially in the context of personalized medicine and targeted cancer therapy.
PIK3CA and AKT1 are genes involved in the PI3K/AKT/mTOR signaling pathway, which plays a crucial role in cell growth, proliferation, and survival. Mutations in these genes can lead to abnormal activation of the pathway, contributing to cancer development and progression. Identifying mutations in PIK3CA and AKT1 can help predict whether a patient is likely to respond to targeted therapies that inhibit this pathway.
Stand Alone Molecular Testing for PIC3CA/AKT1